El-Eshmawy Mervat M, Barakat Amira A, El-Baiomy Azza A, El-Naga Mohamed M Abo, Elbasiony Mohamed
Internal Medicine Department, Mansoura Specialized Medical Hospital, Faculty of Medicine, Mansoura University, P.O. Box: 35516, Mansoura, Egypt.
Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Nutr Metab (Lond). 2025 Mar 11;22(1):19. doi: 10.1186/s12986-025-00899-z.
A bidirectional relationship between hypothyroidism and nonalcoholic fatty liver disease (NAFLD) has been proposed. Fasting hyperglucagonemia in patients with hypothyroidism induced NAFLD needs to be further clarified. The aim of the present study was to determine fasting serum glucagon levels in hypothyroid adults with and without NAFLD. The possible association between fasting glucagon and NAFLD in patients with hypothyroidism was also evaluated.
This study was comprised 60 patients with uncontrolled hypothyroidism and 30 healthy controls matched for age and sex. Patients with hypothyroidism were divided into 2 groups: 30 patients with NAFLD and 30 patients without NAFLD. Diagnosis of NAFLD was based on the combination of hepatic steatosis index (HSI) at a cutoff value of 36 and measurements of steatosis using fibroScan. Anthropometric measurements, lipids profile, homeostasis model assessment of insulin resistance (HOMA-IR), free thyroxine (FT4), triiodothyronine (FT3), thyroid stimulating hormone (TSH) and serum fasting glucagon were assessed.
Serum fasting glucagon concentration was significantly higher in hypothyroid patients with and without NAFLD than in healthy controls; glucagon was also significantly higher in the hypothyroid patients with NAFLD than in those without NAFLD. Fasting glucagon was significantly correlated with waist circumference (WC), body mass index (BMI), TSH, HSI and fibroScan parameters in hypothyroid patients with NAFLD. Fasting glucagon predicts NAFLD in patients with hypothyroidism at a cutoff value 85 ng/L with 90% sensitivity, 100% specificity and p < 0.001. With multivariable analysis, age, BMI and TSH were significant positive predictors of NAFLD in patients with hypothyroidism.
Fasting glucagon concentration may play a role in the development of NAFLD in patients with hypothyroidism. However, the exact underlying mechanism needs further studies.
甲状腺功能减退症与非酒精性脂肪性肝病(NAFLD)之间的双向关系已被提出。甲状腺功能减退症患者空腹高胰高血糖素血症导致非酒精性脂肪性肝病这一情况有待进一步阐明。本研究的目的是测定患有和未患有非酒精性脂肪性肝病的甲状腺功能减退成年患者的空腹血清胰高血糖素水平。同时还评估了甲状腺功能减退症患者空腹胰高血糖素与非酒精性脂肪性肝病之间的可能关联。
本研究纳入了60例甲状腺功能减退未得到控制的患者以及30例年龄和性别匹配的健康对照者。甲状腺功能减退症患者被分为两组:30例患有非酒精性脂肪性肝病的患者和30例未患有非酒精性脂肪性肝病的患者。非酒精性脂肪性肝病的诊断基于肝脂肪变指数(HSI)临界值为36以及使用FibroScan测量脂肪变性情况。评估了人体测量指标、血脂谱、胰岛素抵抗稳态模型评估(HOMA-IR)、游离甲状腺素(FT4)、三碘甲状腺原氨酸(FT3)、促甲状腺激素(TSH)和血清空腹胰高血糖素。
患有和未患有非酒精性脂肪性肝病的甲状腺功能减退症患者的血清空腹胰高血糖素浓度均显著高于健康对照者;患有非酒精性脂肪性肝病的甲状腺功能减退症患者的胰高血糖素水平也显著高于未患有非酒精性脂肪性肝病的患者。在患有非酒精性脂肪性肝病的甲状腺功能减退症患者中,空腹胰高血糖素与腰围(WC)、体重指数(BMI)、TSH、HSI和FibroScan参数显著相关。空腹胰高血糖素预测甲状腺功能减退症患者非酒精性脂肪性肝病的临界值为85 ng/L,敏感性为90%,特异性为100%,p < 0.001。多变量分析显示,年龄、BMI和TSH是甲状腺功能减退症患者非酒精性脂肪性肝病的显著正性预测因子。
空腹胰高血糖素浓度可能在甲状腺功能减退症患者非酒精性脂肪性肝病的发生发展中起作用。然而,确切的潜在机制需要进一步研究。